MarketPulse
N

$NKTX

2 articles found
0 positive
0 negative
2 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Idiopathic Membranous Nephropathy Market Poised to Hit $1B by 2036

IMN market expected to grow nearly 8x from $130M in 2025 to $1B by 2036, driven by novel therapies addressing unmet treatment needs.
NKTXVRTXRHHBYAZNBIIB+2clinical trialspharmaceutical pipeline
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Nkarta to Present at Two Major Healthcare Investment Conferences in March

Nkarta to present at two major healthcare investor conferences in March 2026, showcasing updates on its engineered NK cell therapy pipeline for autoimmune diseases.
NKTXNK cell therapiesautoimmune diseases